StockData
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Ltd. (QNRX) shareholders

QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.36−0.20 (-5.62%)

Close on Nov 17, 2026Market cap $6.75MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
64.7%
1M of 2M shares
Institutional holders
19
1 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
4 buys · 0 sales
Net bought $279.97K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Stonepine GP, LLC
Joint filing with Stonepine Capital Management, LLC (9.99%), Stonepine Capital, L.P. (9.99%) and 1 more
7,594,1669.99%13G (passive) amendmentMar 31, 2026
Integrated Core Strategies (US) LLC
Joint filing with Millennium Management LLC (5.50%), Millennium Group Management LLC (5.50%) and 1 more
3,850,3855.50%13G (passive)May 26, 2026
Stonepine Capital Management, LLC
Joint filing with Stonepine Capital, L.P. (9.90%), Stonepine GP, LLC (9.90%) and 1 more
3,030,9269.90%13G (passive)Dec 10, 2025
Millennium Group Management LLC
Joint filing with Integrated Core Strategies (US) LLC (9.00%), Millennium Management LLC (9.00%) and 1 more
1,901,5859.00%13G (passive)Oct 20, 2025
Neil Shahrestani
Joint filing with Ikarian Capital, LLC (12.60%)
211,53812.60%13G (passive) amendmentJan 31, 2026
Aberdeen Group plc
Joint filing with abrdn Inc. (8.94%)
75,0008.94%13G (passive)Dec 31, 2025
Daniel Schneeberger
Joint filing with ADAR1 Capital Management, LLC (6.90%), ADAR1 Capital Management GP, LLC (6.00%)
58,2306.90%13G (passive)Dec 31, 2025
Resolute Capital Asset Partners LLC
Joint filing with Resolute Capital Asset Partners Fund I LP (8.50%)
50,0008.50%13G (passive)Oct 10, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of QNRXValueChange% of portfolio
Dauntless Investment Group, LLC214,98710.70%$1.04M+18,3950.82%
Ikarian Capital, LLC211,53810.53%$1.02M–0.11%
Stonepine Capital Management, LLC199,4869.93%$965.51K+146,0260.54%
Millennium Management LLC112,3235.59%$543.64K+36,0760.00%
SummitTX Capital, L.P.100,3004.99%$485.45K–0.01%
Woodline Partners LP76,4463.81%$370.00K−3,1360.00%
abrdn plc75,0003.73%$363.00K–0.00%
Soleus Capital Management, L.P.72,7303.62%$352.01K–0.01%
AIGH Capital Management LLC70,0003.49%$338.80K+19,0000.02%
Boothbay Fund Management, LLC59,8382.98%$289.62K–0.00%
Velan Capital Investment Management LP32,3721.61%$156.68K−52,4770.10%
Barclays PLC21,4691.07%$103.91K+20,1690.00%
Birchview Capital, LP20,0001.00%$96.80K–0.05%
XTX Topco Ltd15,0060.75%$72.63KNew0.00%
Morgan Stanley8,0000.40%$38.72K+4,0000.00%
UBS Group AG6,7720.34%$32.78K+4,2600.00%
Rhumbline Advisers2,3320.12%$11.28K+8110.00%
GAMMA Investing LLC4390.02%$2.13K−1,2810.00%
SBI Securities Co., Ltd.3550.02%$1.72K+3530.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026191M64.7%1 / 93 / 30M0M
Q1 2026211M59.0%6 / 74 / 30M0M
Q4 2025181M42.0%14 / 40 / 01M0M
Q3 202540M0.1%0 / 12 / 20M0M
Q2 202560M0.1%1 / 23 / 50M0M
Q1 2025100M0.6%4 / 30 / 80M0M
Q4 2024140M2.2%10 / 31 / 20M0M
Q3 202470M0.2%2 / 40 / 50M0M
Q2 2024100M0.3%5 / 31 / 30M0M
Q1 202480M0.3%7 / 10 / 20M0M
Q4 202330M0.0%2 / 10 / 20M0M
Q3 202330M0.0%3 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Michael MyersChief Executive Officer, Director37,7131.88%Sep 1, 2026
Denise P. CarterChief Operating Officer, Director37,7091.88%Sep 1, 2026
Sally Bridget LawlorChief Financial Officer10,6840.53%Sep 1, 2026
Gordon DunnChief Financial Officer151,0777.52%Dec 27, 2024
Dennis LangerDirector49,6872.47%Oct 26, 2026
Anthony James CulverwellDirector40,3642.01%Sep 1, 2026
Michael T. SemberDirector––Feb 6, 2026
Joseph Patrick CooperDirector––Feb 6, 2026
Natalie Ee Mun LeongDirector––Feb 6, 2026
Stonepine Capital Management, LLC10% owner3,271,100162.87%Mar 31, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Denise P. Carter
Chief Operating Officer, Director
Aug 31, 2026Buy+20,490$4.88$99.99K37,709
Sally Bridget Lawlor
Chief Financial Officer
Aug 31, 2026Buy+10,244$4.88$49.99K10,684
Michael Myers
Chief Executive Officer, Director
Aug 31, 2026Buy+20,490$4.88$99.99K37,713
Anthony James Culverwell
Director
Aug 31, 2026Buy+6,146$4.88$29.99K40,364
Anthony James Culverwell
Director
Aug 27, 2026Award+31,352$5.15$161.46K34,218
Dennis Langer
Director
Aug 27, 2026Award+34,534$5.15$177.85K56,243
Dennis Langer
Director
Oct 14, 2025Buy+15,152$8.49$128.64K15,153
Anthony James Culverwell
Director
Dec 23, 2024Buy+100,000$0.45$45.00K100,317
Gordon Dunn
Chief Financial Officer
Dec 23, 2024Buy+122,221$0.45$55.00K151,077
Denise P. Carter
Chief Operating Officer, Director
Dec 23, 2024Buy+555,556$0.45$250.00K602,648
Michael Myers
Chief Executive Officer, Director
Dec 23, 2024Buy+555,556$0.45$250.00K602,808
Gordon Dunn
Chief Financial Officer
Sep 10, 2024Buy+10,000$0.71$7.10K28,856
Gordon Dunn
Chief Financial Officer
Sep 10, 2024Buy+10,000$0.91$9.10K18,856
Gordon Dunn
Chief Financial Officer
Sep 9, 2024Buy+856$0.80$685856
Gordon Dunn
Chief Financial Officer
Sep 9, 2024Buy+4,000$0.78$3.12K4,856
Gordon Dunn
Chief Financial Officer
Sep 9, 2024Buy+4,000$0.80$3.20K8,856
Michael Myers
Chief Executive Officer, Director
Sep 4, 2024Buy+8,200$0.75$6.15K23,680
Michael Myers
Chief Executive Officer, Director
Sep 4, 2024Buy+23,572$0.80$18.86K47,252
Michael Myers
Chief Executive Officer, Director
Sep 4, 2024Buy+5,322$0.66$3.51K15,480
Denise P. Carter
Chief Operating Officer, Director
Sep 4, 2024Buy+22,988$0.80$18.39K47,092
Denise P. Carter
Chief Operating Officer, Director
Sep 4, 2024Buy+8,825$0.75$6.62K24,104
Michael Myers
Chief Executive Officer, Director
Sep 3, 2024Buy+800$0.62$49610,158
Denise P. Carter
Chief Operating Officer, Director
Sep 3, 2024Buy+1,822$0.63$1.15K11,179
Denise P. Carter
Chief Operating Officer, Director
Sep 3, 2024Buy+4,100$0.66$2.71K15,279
Dennis Langer
Director
Jun 7, 2024Sale−297$0.73$21753

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.9
At 0M shares a day
Change since last report
+17.2%
From 0M shares
Short volume, 20 days
45.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Quoin Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 182,046 shares on Aug 31, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Dennis Langer
Director
Jun 7, 2024297$218Jun 7, 2024Pre IPO Offering

See a number that looks wrong?